Optimization of prostate cancer patient lymph node staging via the integration of neutrophil-lymphocyte ratios, platelet-lymphocyte ratios, and 68 Ga-PSMA-PET-derived SUVmax values.
Yinzhao WangYongxiang TangXiaomei GaoYu GanShuo HuMin-Feng ChenYi CaiPublished in: The Prostate (2022)
SUVmax, the neutrophil-lymphocyte ratio, the platelet-lymphocyte ratio, initial TPSA, and clinical T-stage represent valuable independent predictors of lymph node metastasis in prostate cancer patients, offering an opportunity to further optimize lymph node staging for these patients.
Keyphrases
- lymph node
- pet ct
- prostate cancer
- lymph node metastasis
- peripheral blood
- end stage renal disease
- neoadjuvant chemotherapy
- sentinel lymph node
- ejection fraction
- squamous cell carcinoma
- newly diagnosed
- radical prostatectomy
- chronic kidney disease
- positron emission tomography
- computed tomography
- peritoneal dialysis
- prognostic factors
- papillary thyroid
- radiation therapy
- rectal cancer
- patient reported